Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. DSX
2. GNK
3. INTC
4. III
5. TTEC
6. DAL
7. AWK
8. SPCX
9. ABCB
10. WKC

Go back to Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
(NASDAQ: JAGX) Delayed: 2.25 -0.13 (5.46%)
Previous Close $2.38    52 Week High $4.60 
Open $2.38    52 Week Low $0.81 
Day High $2.39    P/E N/A 
Day Low $2.12    EPS $0.00 
Volume 216,456